Benitec Biopharma Inc. Common Stock

BNTCNASDAQUSD
11.05 USD
0.00 (0.00%)🟢PRE MARKET (AS OF 07:31 PM EDT)
🟢Market: OPEN

BNTC is currently priced at $11.05. The stock presents a bearish profile across the board: technical indicators signal "Strong Sell" and our fundamental models agree with a "Sell" rating. This is driven by a robust Altman Z-Score, a weak Piotroski F-Score of 0/9, negative Return on Equity and a bullish Golden Cross on the moving averages. Valuation metrics suggest BNTC is trading at a discount to its peers, earning an "Attractively Valued" rating.

Technical & fundamental data as of Sep 15, 2026.

Open?$12.11
High?$12.48
Low?$11.00
Prev. Close?$11.05
Volume?239.6K
Avg. Volume?161.9K
VWAP?$11.36
Rel. Volume?1.48x
Bid / Ask
Bid?$9.46 × 100
Ask?$16.19 × 100
Spread?$6.73
Midpoint?$12.83
Valuation & Ratios
Market Cap?385.5M
Shares Out?34.4M
Float?21.1M
Float %?61.4%
P/E Ratio?N/A
P/B Ratio?2.18
EPS?-$1.31
Dividend?0.00%
Ex-Dividend?N/A
News
Profile
Benitec Biopharma Inc is a clinical-stage biotechnology company focused on the advancement of novel genetic medicines. Its technology has the potential to provide a one-shot cure for a wide range of diseases that are addressed by strict ongoing treatment regimens or that have no effective treatment or only palliative care options. The Company is developing a silence and replace-based therapeutic (BB-301) for the treatment of Oculopharyngeal Muscular Dystrophy (OPMD), a chronic, life threatening genetic disorder.
Employees
19
Market Cap
415.0M
Industry
PHARMACEUTICAL PREPARATIONS
Listed
2012-07-11
Address
3940 TRUST WAY
HAYWARD, CA 94545
Phone: (510) 780-0819
Technical OutlookStrong Sell
Strong SellNeutralStrong Buy
Long-Term (Tide)? Bearish(-2/3)
Medium-Term (Wave)? Bearish(-3/3)
Short-Term (Ripple)? Bearish(-3/3)
MA Alignment?Mixed
Full Technical Analysis →
Fundamental OutlookSell
Strong SellNeutralStrong Buy
F-Score?
3
Z-Score?
100
Momentum?
23
Short Sent.?
38
Piotroski F-Score?0/9Weak
Altman Z-Score?42.52Safe
Confidence?48%Low
Full Fundamental Analysis →
Short InterestVery High
Short % of Float?10.50%High
Short Interest?2.2M
Days to Cover?14.3
Free Float21.1M
Avg Daily Volume155.0K
Settlement Date2026-08-31
Financial Health
Current Ratio?34.00Strong
Quick Ratio?34.00Strong
Cash Ratio?33.68Strong
Debt/Equity?0.00Low
ValuationATTRACTIVELY VALUEDvs 1 peers + S&P 500
Score
100/100
P/E?
N/A
P/B?
Peers
100
S&P
70
2.18CHEAP
P/S?
N/A
P/FCF?
N/A
EV/EBITDA?
S&P
97
-4.0CHEAP
EV/Sales?
N/A
Returns & Efficiency
ROE?
S&P
7
-25.7%WEAK
ROA?
S&P
3
-24.9%WEAK
Cash Flow & Enterprise
FCF?$-16623000
Enterprise Value?$205.5M
Fundamentals ratios updated end of day